Eli Lilly and Company

Pharma / Pharma

Info

Overview Core Facts Blog Ratings Executives

Analytics

Company Q&A Industry Q&A Competitors Stock Swings SWOT PEST Porter's Five Forces Score Positive Risks Revenue Segmentation

Financials

Income Statement Balance Sheet Cash Flow Statement

Ratios

Financial Ratios Financial Growth Enterprise Value Key Metrics Dividends

Tools

Due Diligence

Resources

News Clusters SEC Filings Stock Split History Press Releases Insider Trades Owner Earnings Earnings Calendar Web Reports

Financial Growth

Pay attention and research significant changes from year to year values. [ ! ]

Fixed Column	Revenue Growth	Gross Profit Growth	EBIT Growth	Operating Income Growth	Net Income Growth	EPS Growth	EPS Diluted Growth	Weighted Average Shares Growth	Weighted Average Shares Diluted Growth	Dividends per Share Growth	Operating Cash Flow Growth	Free Cash Flow Growth	Ten Y Revenue Growth Per Share	Five Y Revenue Growth Per Share	Three Y Revenue Growth Per Share	Ten Y Operating CF Growth Per Share	Five Y Operating CF Growth Per Share	Three Y Operating CF Growth Per Share	Ten Y Net Income Growth Per Share	Five Y Net Income Growth Per Share	Three Y Net Income Growth Per Share	Ten Y Shareholders Equity Growth Per Share	Five Y Shareholders Equity Growth Per Share	Three Y Shareholders Equity Growth Per Share	Ten Y Dividend per Share Growth Per Share	Five Y Dividend per Share Growth Per Share	Three Y Dividend per Share Growth Per Share	Receivables Growth	Inventory Growth	Asset Growth	Book Value per Share Growth	Debt Growth	R&D Expense Growth	SGA Expenses Growth
2024-12	0.3199	0.3543	0.2492	0.2492	1.0208	1.024	1.0189	-0.002	8.0E-4	0.1525	1.0796	1.1314	1.7373	1.0934	0.6072	1.4069	0.8912	0.2272	4.2809	1.3686	0.9171	0.1104	4.6985	0.6116	1.6553	1.0147	0.5321	-1.0	-1.0	0.2297	0.3163	0.3337	0.18	0.238
2023-12	0.1956	0.2341	0.4487	0.4487	-0.1608	-0.1587	-0.1594	-0.0026	-0.0014	0.1539	-0.4014	-1.6851	0.7743	0.8142	0.4033	-0.1114	-0.1229	-0.3416	0.3443	0.8527	-0.1461	-0.2657	0.2523	0.9268	1.306	1.0114	0.5282	0.3244	0.3394	0.2933	0.0108	0.5534	0.2951	0.0777
2022-12	0.0078	0.0431	0.1211	0.1211	0.1187	0.1268	0.1274	-0.0057	-0.0077	0.152	-0.0242	-0.146	0.5587	0.4558	0.3203	0.6486	0.4718	0.5123	0.8855	36.6961	0.3902	-0.1095	0.0718	3.218	0.9954	0.8817	0.5149	0.0531	0.109	0.014	0.1838	-0.0382	0.0234	0.0013
2021-12	0.1539	0.1022	0.0493	0.0493	-0.0988	-0.0982	-0.0986	-7.0E-4	-9.0E-4	0.1495	0.117	0.2051	0.432	0.557	0.4929	0.2326	0.7465	0.4892	0.5767	1.3791	0.9569	-0.1856	-0.252	0.0352	0.7389	0.6687	0.513	0.1729	-0.0236	0.0465	0.5727	0.0174	0.1544	0.0507

Explore more financial growth data for Eli Lilly and Company!

What is special about us?

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.